PDS Biotechnology Corp. (PDSB)
1.07
-0.09
(-7.76%)
USD |
NASDAQ |
Oct 23, 11:26
PDS Biotechnology Market Cap : 59.84M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 64.87M |
| October 21, 2026 | 69.34M |
| October 20, 2026 | 53.71M |
| October 19, 2026 | 51.25M |
| October 16, 2026 | 63.19M |
| October 15, 2026 | 72.70M |
| October 14, 2026 | 78.85M |
| October 13, 2026 | 89.47M |
| October 12, 2026 | 85.00M |
| October 09, 2026 | 77.17M |
| October 08, 2026 | 57.04M |
| October 07, 2026 | 59.56M |
| October 06, 2026 | 58.44M |
| October 05, 2026 | 67.11M |
| October 02, 2026 | 41.86M |
| October 01, 2026 | 39.49M |
| September 30, 2026 | 41.98M |
| September 29, 2026 | 41.54M |
| September 28, 2026 | 42.83M |
| September 25, 2026 | 44.58M |
| September 24, 2026 | 44.74M |
| September 23, 2026 | 46.07M |
| September 22, 2026 | 50.89M |
| September 21, 2026 | 47.08M |
| September 18, 2026 | 45.04M |
| Date | Value |
|---|---|
| September 17, 2026 | 47.10M |
| September 16, 2026 | 55.40M |
| September 15, 2026 | 32.73M |
| September 14, 2026 | 22.32M |
| September 11, 2026 | 16.49M |
| September 10, 2026 | 17.63M |
| September 09, 2026 | 16.39M |
| September 08, 2026 | 16.78M |
| September 04, 2026 | 12.30M |
| September 03, 2026 | 12.30M |
| September 02, 2026 | 11.86M |
| September 01, 2026 | 11.41M |
| August 31, 2026 | 11.97M |
| August 28, 2026 | 11.79M |
| August 27, 2026 | 12.19M |
| August 26, 2026 | 12.48M |
| August 25, 2026 | 12.39M |
| August 24, 2026 | 12.12M |
| August 21, 2026 | 12.22M |
| August 20, 2026 | 11.68M |
| August 19, 2026 | 11.22M |
| August 18, 2026 | 11.63M |
| August 17, 2026 | 12.33M |
| August 14, 2026 | 12.90M |
| August 13, 2026 | 13.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.394B |
| Alnylam Pharmaceuticals, Inc. | 29.92B |
| Anika Therapeutics, Inc. | 281.18M |
| Savara, Inc. | 870.89M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price | 1.07 |
| Earnings Yield | -59.84% |